Mon panier

LRRK2

LRRK2 Informations sur la molécule

Nom anglaisLeucine-rich repeat serine/threonine-protein kinase 2Nombre de médicaments commercialisés0
Nombre de médicaments cliniques11Alias de la ciblePARK8,LRRK2,Leucine Rich Repeat Kinase 2,Leucine-Rich Repeat Serine/Threonine-Protein Kinase 2,Parkinson Disease (Autosomal Dominant) 8,Augmented In Rheumatoid Arthritis 17,Dardarin,AURA17,RIPK7,ROCO2,Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,DKFZp434H2111,FLJ45829
Phase de R&D la plus avancéePhase 2 Clinical
Nom anglaisLeucine-rich repeat serine/threonine-protein kinase 2
Alias de la ciblePARK8,LRRK2,Leucine Rich Repeat Kinase 2,Leucine-Rich Repeat Serine/Threonine-Protein Kinase 2,Parkinson Disease (Autosomal Dominant) 8,Augmented In Rheumatoid Arthritis 17,Dardarin,AURA17,RIPK7,ROCO2,Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,DKFZp434H2111,FLJ45829
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques11
Phase de R&D la plus avancéePhase 2 Clinical

Demande de produit

LRRK2Alias de la molécule

PARK8,Leu-rich repeat,LRR-containing protein kinase 2,Dardarin

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
BIIB-094BIIB-094; ION-859; IONIS-BIIB7RxPhase 2 ClinicalBiogen IncParkinson Disease
Details
NEU-411NEU-411Phase 2 ClinicalNeuron23 IncParkinsonian Disorders; Parkinson Disease
Details
DNL-151BIIB122; DNL151; BIIB-122; DNL-151Phase 2 ClinicalGenentech IncParkinson Disease
Details
VRN-01VRN-01Phase 1 ClinicalVoronoi IncGlioblastoma
Details
LRRK2 Kinase Inhibitors (Oncodesign/Servier)ODS-2005294Phase 1 ClinicalNeoplasms; Parkinson Disease; Central Nervous System Diseases
Details
OPM-201OPM-201; S-221237Phase 1 ClinicalOncodesign BiotechnologyParkinson Disease
Details
ARV-102ARV-102Phase 1 ClinicalArvinas IncSupranuclear Palsy, Progressive; Parkinson Disease
Details
HT-4253HT-4253Phase 1 ClinicalHalia Therapeutics IncAlzheimer Disease
Details
FB418FB418Phase 1 Clinical1st Biotherapeutics IncParkinsonian Disorders; Parkinson Disease; Amyotrophic Lateral Sclerosis
Details
WXWH0226WXWH0226; WXWH-0226Phase 1 ClinicalGuizhou Inochini Technology Co Ltd, Wuxi Apptec Co LtdParkinson Disease
Details
BT-0267BT 267; BT-0267ClinicalBrenig Therapeutics IncParkinson Disease
Details
  • Informations sur la molécule
  • Demande de produit
  • Informations sur les médicaments cliniques